Clinical Trial Update: Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on dexmedetomidine and outcomes after cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Valve Diseases

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Xijing Hospital | Conditions: Heart Valve Diseases, Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED